Amphiregulin as a novel diagnostic and prognostic biomarker of hepatocellular carcinoma before and after locoregional treatment
Abstract Background Hepatocellular carcinoma is a highly prevalent tumor worldwide. Amphiregulin is a ligand of the epidermal growth factor receptor. Its elevation is linked to different inflammatory and neoplastic conditions. Therefore, amphiregulin may represent a potential diagnostic target in HC...
Saved in:
Main Authors: | Amira Isaac, Sherif Mounir Mohamed, Osama Ashraf Ahmed, Ahmed Gamal Mohamed Hassan, Hany Samir Rasmy |
---|---|
Format: | article |
Language: | EN |
Published: |
SpringerOpen
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/7eb938a4cc2b4c24b7e6e32a4cc6c076 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Transcatheter chemoembolization plus percutaneous radiofrequency ablation versus laparoscopic radiofrequency ablation: improved outcome for inoperable hepatocellular carcinoma
by: Bin Chai, et al.
Published: (2021) -
Contrast-enhanced Ultrasound Assessment of Treatment Response in a Patient with Multifocal Hepatocellular Carcinoma Treated with Transarterial Chemo and Radioembolization
by: Esika Savsani, Mohamed Tantawi, MD, Corinne E. Wessner, MBA, RDMS, RVT, Philip Lee, MD, Andrej Lyshchik, MD, PhD, Kevin Anton, MD, PhD, Colette M. Shaw, MD, Ji-Bin Liu, MD, John R. Eisenbrey, PhD
Published: (2021) -
Early experience with laparoscopic treatment of liver tumors using a separable cluster electrode with a no-touch technique
by: Hyun Hong, et al.
Published: (2020) -
Development of a Model to Predict Liver Decompensation prior to Transarterial Chemoembolization Refractoriness in Patients with Intermediate-Stage Hepatocellular Carcinoma
by: Joel Ferreira-Silva, et al.
Published: (2021) -
Hyperthermia ablation combined with transarterial chemoembolization versus monotherapy for hepatocellular carcinoma: A systematic review and meta‐analysis
by: Zheng Li, et al.
Published: (2021)